MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Telomir Pharmaceuticals, Inc. (TELO)
Telomir Pharmaceuticals, Inc. (TELO)
source: myfinsight.com
Proceeds from issuance of
insurance loan payable
$224,789
Net cash provided by
financing activities
$47,351
Canceled cashflow
$177,438
Net change in cash
-$1,726,159
Canceled cashflow
$47,351
Stock-based compensation
expense
$39,803
Due to related
parties
$26,592
Repayment to officer
-$155,518
Repayments on insurance
loan payable
$21,920
Net cash used in
operating activities
-$1,773,510
Canceled cashflow
$66,395
Net loss
-$990,947
Accrued compensation -
officer
-$417,470
Trade accounts
payable and accrued...
-$257,153
Prepaid expenses
$174,335
Back